No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
384 |
4. Check minimum number of eventsNone |
384 |
5. Include endpointsNone |
384 |
6. Filter based on genotype QC (FinnGen only) |
384 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M12
- Name in latin
- Rheumatismus palindromicus
Similar endpoints
↥List of similar endpoints to
Palindromic rheumatism
based on the number of shared cases.
Similar with more cases:
- Other specific arthropathies, wide
- Polyarthropathies
- Finngen Rheumatological endpoints
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1936 | 1191 | 735 |
| Only index persons | 1767 | 1120 | 647 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.02 |
| Only index persons | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 52.21 | 51.50 | 53.40 |
| Only index persons | 51.77 | 51.02 | 53.08 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 384 | 245 | 139 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.06 |
| Median age at first event (years) | 52.38 | 50.77 | 55.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 356
- Matched controls
- 3560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M12.3
ICD-10 Finland
Palindromic rheumatism
+∞
323.0
322
*
P01BA02
ATC
hydroxychloroquine; oral
358.5
312.5
282
37
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
113.5
226.2
237
61
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
+∞
190.1
165
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
77.7
164.1
182
47
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
130.8
156.1
160
22
A07EC01
ATC
sulfasalazine; oral, rectal
66.4
130.8
149
38
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
81.2
118.2
130
25
L88
ICPC
Rheumatoid/seropositive arthritis
225.6
86.5
86
5
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1024.1
85.2
80
*
H02AB06
ATC
prednisolone; systemic
10.4
83.0
286
1000
M13.9
ICD-10 Finland
Arthritis, unspecified
52.6
74.1
88
22
M25.5
ICD-10 Finland
Pain in joint
9.7
68.8
165
291
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
117.4
63.4
67
7
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
249.1
62.3
62
*
L04AA13
ATC
leflunomide; oral
701.0
61.7
59
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
19.9
60.5
94
63
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
+∞
57.9
54
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
229.9
57.9
58
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
+∞
54.6
51
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
71.9
48.9
55
9
M17.1
ICD-10 Finland
Other primary gonarthrosis
18.4
46.2
73
49
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
64.1
39.3
45
8
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
16.7
39.2
64
46
M01CB01
ATC
sodium aurothiomalate; parenteral
+∞
38.2
36
*
71220
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Palindromic rheumatism
+∞
33.9
32
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
316.3
29.2
29
*
L04AB01
ATC
etanercept; parenteral
70.0
28.4
32
5
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
67.6
27.4
31
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.6
27.0
169
713
NH3EA
NOMESCO Finland
Feet X-ray examination with load
279.7
26.0
26
*
H02AB07
ATC
prednisone; oral
5.0
24.3
87
218
ZX140
NOMESCO Finland
Intra articular
+∞
24.2
23
*
M01AH05
ATC
etoricoxib; oral
3.0
22.0
228
1314
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
21.0
20
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
8.8
20.2
44
56
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
+∞
20.0
19
*
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
+∞
20.0
19
*
L20
ICPC
Joint symptom/complaint NOS
15.8
19.8
32
22
M01AE02
ATC
naproxen; oral, rectal
2.8
19.7
224
1329
M01AH01
ATC
celecoxib; oral (coxibs)
4.0
19.3
85
256
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
12.0
19.2
35
32
L04AB04
ATC
adalimumab; parenteral
46.6
18.4
22
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
18.4
177
931
M79.0
ICD-10 Finland
Rheumatism, unspecified
11.6
18.4
34
32
N02AX02
ATC
tramadol; systemic, rectal
2.8
18.2
161
805
TNG10
NOMESCO Finland
Puncture of knee
+∞
17.9
17
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.7
17.8
174
918
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
14.2
17.3
29
22
M01CB03
ATC
auranofin; oral
94.5
16.7
18
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
25.9
16.2
22
9
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
6.8
16.0
41
67
A02BC02
ATC
pantoprazole; systemic
2.6
15.5
244
1633
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
47.2
15.2
18
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
15.0
14.8
24
17
M13.0
ICD-10 Finland
Polyarthritis, unspecified
83.6
14.7
16
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
156.1
14.6
15
*
NF1AA
NOMESCO Finland
Hip X-ray examination
7.4
14.3
34
50
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
21.1
13.9
20
10
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
+∞
13.6
13
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
+∞
13.6
13
*
H02AB04
ATC
methylprednisolone; systemic
3.5
13.6
69
230
M01AC06
ATC
meloxicam; systemic, rectal
2.5
13.6
137
710
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
145.2
13.5
14
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
17.6
13.1
20
12
M79.6
ICD-10 Finland
Pain in limb
2.5
13.1
127
642
WX320
NOMESCO Finland
Spinalanesthesy
3.3
12.9
72
257
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
7.1
12.8
31
47
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
72.5
12.7
14
*
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
21.0
12.6
18
9
NG1DA
NOMESCO Finland
X-ray of knees
+∞
12.6
12
*
SPAT1202
SPAT
Intra-articular injection
12.3
12.5
22
19
L15
ICPC
Knee symptom/complaint
3.2
12.1
67
238
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
23.8
11.7
16
7
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
+∞
11.5
11
*
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
+∞
11.5
11
*
7148X
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies
+∞
11.5
11
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
11.5
130
699
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
6.1
11.5
31
55
M01AX17
ATC
nimesulide; oral
2.7
11.3
91
407
M19.0
ICD-10 Finland
Primary arthrosis of other joints
11.7
11.2
20
18
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.8
11.2
82
347
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
7.8
11.2
25
34
M01AB55
ATC
diclofenac, combinations; oral
5.1
10.9
34
72
M20.1
ICD-10 Finland
Hallux valgus (acquired)
8.9
10.7
22
26
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
113.2
10.5
11
*
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
+∞
10.5
10
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
+∞
10.5
10
*
M06
ICD-10 Finland
Other rheumatoid arthritis
+∞
10.5
10
*
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
+∞
10.5
10
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
10.4
48
148
M35.7
ICD-10 Finland
Hypermobility syndrome
33.6
10.4
13
*
M01AH02
ATC
rofecoxib; oral
3.2
10.1
54
186
L11
ICPC
Wrist symptom/complaint
4.4
10.1
36
88
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
17.3
10.0
15
9
M10.9
ICD-10 Finland
Gout, unspecified
6.9
9.9
24
37
L04AX01
ATC
azathioprine; systemic
5.9
9.9
27
49
M13.8
ICD-10 Finland
Other specified arthritis
26.9
9.9
13
5
S18
ICPC
Laceration/cut
2.1
9.8
139
818
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.5
9.8
28
54
J45.9
ICD-10 Finland
Asthma, unspecified
2.7
9.7
70
294
L04AA01
ATC
[U] ciclosporin; systemic
18.1
9.5
14
8
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
102.6
9.5
10
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
102.6
9.5
10
*
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
+∞
9.4
9
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.9
9.4
38
105
M79.7
ICD-10 Finland
Fibromyalgia
9.4
9.1
18
20
R06AE07
ATC
cetirizine; oral
2.0
9.1
157
997
L04AB06
ATC
golimumab; parenteral
37.7
9.1
11
*
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
9.0
132
783
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
24.7
9.0
12
5
M35.3
ICD-10 Finland
Polymyalgia rheumatica
6.6
8.9
22
35
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.5
8.9
75
342
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
6.4
8.8
22
36
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
14.5
8.8
14
10
N02BE01
ATC
paracetamol; systemic, rectal
2.3
8.8
295
2422
M02AA10
ATC
ketoprofen; topical
2.7
8.7
63
262
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
51.2
8.7
10
*
A02BC03
ATC
lansoprazole; oral
2.2
8.5
103
560
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
8.4
67
295
J01DB01
ATC
cefalexin; oral
2.2
8.4
286
2327
NDG30
NOMESCO Finland
Fusion of wrist, total
+∞
8.4
8
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
+∞
8.4
8
*
L04AA17
ATC
[U] adalimumab; parenteral
+∞
8.4
8
*
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
+∞
8.4
8
*
M54.5
ICD-10 Finland
Low back pain
2.1
8.2
110
624
HMAK
NOMESCO Finland
NA
2.9
8.2
52
201
M01AB05
ATC
diclofenac; systemic, rectal
1.9
8.2
228
1701
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
8.2
41
135
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
8.2
57
233
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
8.2
82
409
J01AA02
ATC
doxycycline; systemic
2.1
8.1
276
2227
R03DC03
ATC
montelukast; oral
2.6
8.0
60
257
SPAT1249
SPAT
Treatment-related counselling outside office
1.9
7.9
145
928
N03AX16
ATC
pregabalin; oral
2.3
7.9
80
399
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
7.8
78
387
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
15.5
7.8
12
8
L12
ICPC
Hand/finger symptom/complaint
2.8
7.7
51
200
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
7.7
94
508
A02BC05
ATC
esomeprazole; systemic
1.9
7.7
139
883
M04AA01
ATC
allopurinol; systemic
3.0
7.6
44
160
RF420
NOMESCO Finland
NA
18.8
7.6
11
6
R03AK07
ATC
formoterol and budesonide; inhalant
2.3
7.6
78
390
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
81.7
7.4
8
*
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
81.7
7.4
8
*
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
81.7
7.4
8
*
L04AA11
ATC
[U] etanercept; parenteral
81.7
7.4
8
*
L28
ICPC
Limited function/disability (L)
2.7
7.4
53
219
SPAT1211
SPAT
Application of soft bandage
3.4
7.4
35
111
ND2BG
NOMESCO Finland
MRI of hand
+∞
7.3
7
*
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
+∞
7.3
7
*
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
+∞
7.3
7
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
+∞
7.3
7
*
M07.3
ICD-10 Finland
Other psoriatic arthropathies
+∞
7.3
7
*
L03
ICPC
Low back symptom/complaint
2.2
7.3
82
428
R01AD08
ATC
fluticasone; nasal
2.0
7.2
106
617
P01BA01
ATC
chloroquine; systemic
30.7
7.2
9
*
1XC02
NOMESCO Finland
NA
20.5
7.2
10
5
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.0
7.2
99
563
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
12.4
7.1
12
10
J01FA06
ATC
roxithromycin; oral
1.9
7.1
140
910
SPAT1263
SPAT
Sampling
1.9
7.0
142
933
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
14.1
6.9
11
8
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.7
6.9
48
197
A46
ICD-10 Finland
Erysipelas
2.6
6.9
50
209
SPAT1153
SPAT
Removal of sutures
2.0
6.9
102
598
L17
ICPC
Foot/toe symptom/complaint
2.1
6.8
81
431
SPAT1216
SPAT
Assessment of functional ability
2.6
6.8
52
222
XX9XE
NOMESCO Finland
Other ultrasound examination
40.8
6.8
8
*
RF410
NOMESCO Finland
NA
17.1
6.8
10
6
XA402
NOMESCO Finland
ENMG
7.4
6.8
15
21
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.7
6.8
46
185
L40.5
ICD-10 Finland
Arthropathic psoriasis
23.0
6.7
9
*
SPAT1097
SPAT
Recording of ECG
2.5
6.7
54
238
R03BA01
ATC
beclometasone; inhalant
2.4
6.6
55
249
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
12.6
6.6
11
9
WZA10
NOMESCO Finland
Long statement of health and health related matters
12.6
6.6
11
9
R03AC02
ATC
salbutamol; inhalant
1.8
6.6
177
1269
M02AA07
ATC
piroxicam; topical
1.9
6.5
119
749
M17.5
ICD-10 Finland
Other secondary gonarthrosis
71.0
6.4
7
*
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
71.0
6.4
7
*
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
14.6
6.4
10
7
-48
ICPC
Clarification/discussion RFE/demand
8.4
6.4
13
16
M10.0
ICD-10 Finland
Idiopathic gout
8.4
6.4
13
16
L90
ICPC
Osteoarthrosis of knee
6.1
6.4
16
27
R52.9
ICD-10 Finland
Pain, unspecified
3.1
6.4
33
113
B01AF01
ATC
rivaroxaban; oral
3.1
6.3
34
119
M03BX02
ATC
tizanidine; oral
1.8
6.3
208
1579
M01AH03
ATC
valdecoxib; oral
3.8
6.3
25
69
M15.8
ICD-10 Finland
Other polyarthrosis
18.4
6.3
9
5
212
Kela drug reimbursment
Gout
+∞
6.3
6
*
NF1DA
NOMESCO Finland
X-ray of hips
+∞
6.3
6
*
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
+∞
6.3
6
*
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
3.7
6.3
26
75
NDL52
NOMESCO Finland
Tenosynovectomy of hand
27.2
6.3
8
*
A02BA02
ATC
ranitidine; systemic
2.1
6.2
73
386
M05BA04
ATC
alendronic acid; oral
3.1
6.2
33
115
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
6.2
52
237
SPAT1059
SPAT
Spirometry at the office
3.7
6.1
25
71
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
6.1
171
1232
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
8.8
6.1
12
14
WX204
NOMESCO Finland
Axillary plexus blockaced
5.4
6.1
17
33
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
6.1
114
720
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.9
6.0
18
38
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
189
366
9.20
105.30
1.7
1.1
u/ml
73.2
2.5
11.20
104
156
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
183
392
8.01
91.11
1.7
1.2
iu/ml
76.1
14.0
7.10
115
114
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
60
25
28.26
85.95
1.6
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
54
22
28.40
77.79
1.9
1.1
e6/l
13988.1
19128.3
0.16
44
16
(3037522) Nuclear Ab [Titer] in Serum
150
306
7.40
76.77
1.5
1.2
titre
521.7
561.3
0.09
47
61
(3021788) Differential panel - Synovial fluid
47
13
41.06
76.21
1.5
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
293
1408
5.56
50.43
10.7
4.8
e9/l
0.0
0.0
1.34
280
1215
(3001604) Monocytes [#/volume] in Blood
291
1402
5.44
49.60
10.7
4.8
e9/l
0.6
0.6
0.74
278
1204
(3019198) Lymphocytes [#/volume] in Blood
294
1436
5.47
49.01
10.7
4.8
e9/l
1.8
2.0
1.09
280
1259
(3022096) Basophils/100 leukocytes in Blood
273
1285
4.89
47.02
10.8
4.9
%
0.8
0.7
1.40
265
1195
(3013115) Eosinophils [#/volume] in Blood
294
1470
5.27
46.59
11.0
5.0
e9/l
0.2
0.2
0.20
283
1288
(3006504) Eosinophils/100 leukocytes in Blood
276
1320
4.88
46.26
10.9
4.9
%
3.0
2.9
0.45
270
1223
(3018010) Neutrophils/100 leukocytes in Blood
277
1335
4.86
45.77
10.7
4.8
%
58.0
57.2
0.56
271
1247
(3019069) Monocytes/100 leukocytes in Blood
275
1329
4.77
44.98
11.5
5.1
%
8.7
8.6
0.28
270
1243
(3002030) Lymphocytes/100 leukocytes in Blood
277
1359
4.73
44.04
11.2
5.0
%
27.3
27.7
0.29
271
1262
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
54
63
9.81
43.68
1.9
1.4
iu/ml
0.8
0.0
—
8
12
(3013650) Neutrophils [#/volume] in Blood by Automated count
310
1689
5.34
41.97
14.7
8.9
e9/l
4.0
4.1
0.33
295
1475
(3021440) Promyelocytes/100 leukocytes in Blood
97
232
5.26
39.63
4.8
4.4
%
0.1
0.1
0.02
25
69
(3017181) Myelocytes/100 leukocytes in Blood
97
249
4.87
36.20
4.9
4.3
%
0.6
0.9
0.41
24
77
(3025159) Blasts/100 leukocytes in Blood
88
215
5.01
34.77
5.0
4.5
%
0.0
0.1
0.60
21
57
(3002179) Metamyelocytes/100 leukocytes in Blood
90
225
4.92
34.58
4.7
4.3
%
0.4
0.5
0.10
18
49
(3013707) Erythrocyte sedimentation rate by Westergren method
335
2101
5.66
33.75
10.9
3.3
mm/h
14.7
11.9
2.72
330
1912
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
10
24.40
31.69
1.4
1.0
e6/l
2217.9
75036.0
—
16
5
(3026493) Urate [Moles/volume] in Serum or Plasma
163
672
3.48
30.57
3.3
2.3
umol/l
336.8
10878.4
4.48
151
584
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
50
81
6.95
30.42
1.7
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
26
17
16.33
29.94
1.5
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
158
655
3.40
29.12
6.9
4.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
30
27
11.97
28.79
1.4
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
192
914
3.20
27.77
9.8
4.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
306
2006
3.59
23.92
7.5
3.8
—
—
—
0
0
(3019225) pH of Specimen
84
266
3.76
22.97
4.3
4.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
20
18
11.67
19.03
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
45
108
4.59
17.72
2.3
2.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
66
214
3.52
17.16
3.3
2.9
g/l
10.0
10.3
0.31
58
196
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
200
1171
2.48
16.94
2.6
2.2
nmol/l
80.6
75.3
1.60
187
1051
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
32
66
5.20
15.02
1.3
1.3
u/ml
2.6
15.5
—
5
14
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40
100
4.35
14.92
2.2
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
52
162
3.56
14.28
4.1
2.1
e9/l
3.8
3.9
0.09
41
133
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
43
6.15
14.17
3.2
2.5
e9/l
3.6
4.4
1.12
25
43
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
31
67
4.95
13.79
1.3
1.3
u/ml
4.0
3.1
—
5
10
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
46
5.74
13.24
3.2
3.3
%
56.0
55.6
0.05
25
46
(3021879) Hepatitis B virus core Ab [Presence] in Serum
52
179
3.20
12.16
1.3
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
215
1440
2.12
11.66
4.9
3.2
estimate
0.0
0.0
0.00
62
264
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
212
1418
2.11
11.47
7.1
6.8
mmol/l
1.2
1.2
2.24
184
1203
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
49
176
3.05
10.63
4.4
3.6
kpa
5.3
5.1
0.43
44
166
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
46
166
3.01
9.89
4.1
3.6
mmol/l
3.3
2.0
1.34
34
135
(3042936) Bacteria identified in Isolate by Culture
75
352
2.41
9.63
1.7
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
61
4.31
9.59
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
33
5.67
9.54
2.3
5.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
208
1445
1.96
9.46
6.4
4.6
estimate
0.0
0.0
0.50
64
266
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
352
2992
3.12
9.41
24.5
12.4
mg/l
15.7
25.5
11.79
336
2299
(3028026) IgM [Mass/volume] in Serum or Plasma
47
181
2.82
8.99
2.2
1.9
g/l
1.1
1.5
0.74
41
164
(3009261) Glucose [Presence] in Urine by Test strip
206
1455
1.90
8.63
5.1
3.3
estimate
0.0
0.0
0.50
64
252
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
77
384
2.26
8.54
4.1
4.2
%
31.9
33.0
0.37
68
256
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
134
827
1.95
8.41
1.9
2.1
u/l
94.6
286.1
1.46
125
785
(3017143) Hepatitis C virus Ab [Presence] in Serum
61
286
2.35
7.78
1.3
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
73
377
2.16
7.37
1.3
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
5
20.47
7.17
2.3
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
185
1321
1.77
6.98
16.0
8.4
e9/l
0.0
0.0
0.77
166
1071
(3013512) EKG study
132
854
1.83
6.93
4.2
3.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
34
130
2.77
6.59
4.3
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
121
773
1.83
6.56
5.9
3.4
estimate
0.0
0.0
0.50
63
259
(3044927) Protein electrophoresis panel - Urine
13
25
5.35
6.53
1.2
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
75
412
2.02
6.39
2.4
2.4
umol/l
12.4
14.0
1.10
70
388
(3037121) Protein [Mass/volume] in Urine
30
109
2.90
6.38
3.6
3.5
g/l
0.5
0.3
—
9
44
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
340
2967
2.27
6.34
19.0
11.4
ml/min/173m2
82.7
81.1
0.83
321
2425
(3015377) Calcium [Moles/volume] in Serum or Plasma
143
969
1.76
6.31
2.6
3.8
mmol/l
2.3
2.4
0.56
123
855
(3041096) Erythrocytes [Presence] in Urine by Automated
126
823
1.79
6.31
4.6
3.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
223
1714
1.72
6.21
4.9
4.7
mmol/l
6.5
6.8
1.11
212
1606
(3007164) IgA [Mass/volume] in Serum or Plasma
94
567
1.87
6.07
1.7
1.6
g/l
2.5
2.4
0.36
65
353
(3022217) INR in Platelet poor plasma by Coagulation assay
62
327
2.07
5.88
23.5
16.9
inr
1.3
1.2
0.23
27
49
(3009542) Hematocrit [Volume Fraction] of Blood
239
2837
0.58
5.86
21.2
13.3
%
40.4
39.7
0.75
167
2029
(3004588) Protein electrophoresis panel - Serum or Plasma
41
184
2.38
5.75
2.1
2.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
29
4.60
5.55
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
159
1144
1.67
5.46
5.3
3.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
172
1277
1.63
5.14
6.3
5.9
mmol/l
1.2
1.2
1.71
158
1159
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
99
642
1.73
4.93
3.2
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
113
765
1.68
4.79
4.2
4.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
90
580
1.72
4.55
3.1
2.5
e6/l
3.2
7.5
2.07
77
512
(3015235) Bicarbonate [Moles/volume] in Capillary blood
21
77
2.83
4.42
3.6
2.5
mmol/l
26.7
25.3
0.51
15
69
(40768804) Tissue Pathology biopsy report
163
1227
1.57
4.41
2.5
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
115
798
1.63
4.38
3.5
3.1
ng/l
1182.9
1235.4
0.06
101
674
(3024561) Albumin [Mass/volume] in Serum or Plasma
160
1208
1.56
4.23
4.8
5.1
g/l
34.5
35.6
1.36
147
1131
(3007853) Bacteria identified in Skin by Aerobe culture
52
290
1.92
4.21
1.6
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
136
991
1.58
4.20
4.2
3.5
e6/l
202.4
80.4
0.32
96
690
(3005570) Glucose [Moles/volume] in Urine
13
38
3.51
3.93
1.6
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
98
673
1.61
3.84
2.5
1.9
mg/l
3.3
3.1
0.39
88
565
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
70
442
1.71
3.78
2.2
2.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
42
226
1.96
3.77
2.2
3.1
g/l
65.0
66.7
0.88
42
207
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
163
1267
1.50
3.63
5.0
3.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
41
3.25
3.52
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
76
500
1.65
3.51
1.5
1.6
nmol/l
1003.4
1206.6
1.27
65
378
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
6
10.13
3.51
1.2
1.2
iu/ml
244.8
405.4
—
6
6
(3027945) Reticulocytes/100 erythrocytes in Blood
51
301
1.80
3.47
2.9
2.8
%
1.5
1.8
2.02
45
273
(3044640) Blood type and Crossmatch panel - Blood
118
871
1.51
3.31
3.2
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
70
459
1.64
3.27
1.3
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
33
172
2.00
3.26
2.6
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
144
1118
1.46
3.12
1.9
1.9
pmol/l
95.2
94.9
0.03
89
578
(3023520) Reticulocytes [#/volume] in Blood
40
229
1.83
3.01
1.7
3.0
e9/l
63.4
70.8
0.99
35
178
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
143
1115
1.45
3.00
4.4
3.4
ng/l
23.8
36.7
1.16
106
761
(3021901) Oxygen saturation in Capillary blood
15
57
2.70
3.00
3.1
2.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
52
325
1.69
2.91
1.4
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
109
2.18
2.91
1.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
88
627
1.52
2.88
1.9
1.5
mg/l
0.8
1.2
1.94
70
479
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
9
6.75
2.87
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
13
47
2.83
2.84
1.4
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
84
2.33
2.82
1.6
1.4
ug/g
301.0
295.9
—
10
52
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
42
250
1.76
2.79
3.3
3.5
mmol/l
1.2
1.2
0.50
37
207
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
98
2.21
2.76
1.3
1.6
g/l
3.6
3.6
0.01
16
66
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
98
2.21
2.76
1.3
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
36
206
1.82
2.73
2.4
4.0
ng/l
79.1
85.4
0.18
31
181
(3020564) Creatinine [Moles/volume] in Serum or Plasma
353
3308
1.83
2.71
26.1
14.7
umol/l
75.0
75.7
0.17
353
3308
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
19
4.28
2.69
1.4
2.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
19
4.28
2.69
1.3
2.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
19
4.28
2.69
1.4
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
19
4.28
2.69
1.4
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
155
1249
1.40
2.64
2.9
2.6
ug/l
116.4
124.8
0.25
150
1168
(3010503) CD19 cells [#/volume] in Blood
7
15
4.73
2.61
1.6
2.2
e9/l
0.2
0.2
—
7
15
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
310
2823
1.51
2.59
5.3
4.5
mu/l
1.8
2.4
0.67
293
2562
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
7
7.22
2.55
1.2
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
88
2.22
2.55
1.4
1.7
g/l
9.3
10.1
0.40
19
74
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
218
1872
1.38
2.49
3.3
2.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
89
2.19
2.49
2.8
3.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
292
0.43
2.49
1.3
1.8
—
—
—
0
0
(4024509)
8
21
3.87
2.47
2.5
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
221
1.75
2.45
1.4
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
51
334
1.61
2.40
1.3
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
66
2.32
2.27
1.1
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
35
211
1.72
2.26
3.0
2.8
ml/min/173m2
73.2
64.0
0.78
17
79
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
60
2.38
2.24
1.4
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
9
5.61
2.22
2.2
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
206
0.42
2.14
1.1
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
187
1592
1.34
2.14
6.8
6.7
umol/l
9.6
11.4
2.24
178
1522
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
312
2878
1.45
2.13
5.3
5.4
mmol/mol
38.6
39.9
1.95
292
2658
(3021960) Folate [Moles/volume] in Serum or Plasma
86
650
1.42
2.06
1.6
1.5
nmol/l
21.7
21.5
0.03
74
549
(40768797) Stomach Pathology biopsy report
58
406
1.50
2.06
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
142
1166
1.35
2.05
9.7
7.5
inr
1.2
1.2
0.06
43
370
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
15
4.05
2.04
1.0
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
15
4.05
2.04
1.0
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
44
2.54
2.03
1.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
32
2.85
2.01
1.6
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
32
2.85
2.01
1.6
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
32
2.85
2.01
1.6
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
108
855
1.37
1.96
3.6
3.0
e6/l
13.7
60.9
2.73
90
651
(3020779) Urea [Moles/volume] in Serum or Plasma
37
236
1.63
1.96
4.7
7.8
mmol/l
10.5
9.2
0.35
37
222
(3003327) Ova and parasites identified in Stool by Light microscopy
17
85
2.05
1.93
1.2
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
65
473
1.45
1.91
1.8
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
189
2149
0.76
1.88
3.5
3.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
339
3198
1.51
1.86
19.7
14.7
mmol/l
4.0
4.0
0.28
332
3099
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
161
1.73
1.84
1.7
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
338
3189
1.50
1.82
19.4
14.6
mmol/l
139.8
139.7
0.23
330
3092
(40761535) Cells panel - Urine sediment
35
225
1.61
1.81
5.3
3.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
13
61
2.17
1.73
1.3
1.2
u/l
12.3
12.2
—
6
49
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
61
2.17
1.73
1.0
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
82
634
1.37
1.72
1.6
1.7
pmol/l
451.6
13645300.3
0.50
70
535
(3030467) Casts [#/volume] in Urine by Automated count
96
763
1.34
1.69
3.4
2.9
e6/l
0.1
0.7
3.29
70
563
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
31
2.61
1.67
1.0
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
10
43
2.36
1.61
1.2
1.1
u/ml
1.6
1.7
—
5
11
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
92
1.89
1.58
1.4
1.6
g/l
2.8
3.0
0.24
17
68
(3002256) Pathology report gross observation
56
412
1.42
1.57
1.5
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
82
646
1.34
1.52
5.4
3.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
216
0.49
1.52
1.3
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
88
701
1.33
1.52
11.2
6.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6
21
2.89
1.51
1.2
1.2
—
0.1
—
0
7
(1761868) Lipid panel - Serum or Plasma
99
1200
0.76
1.51
3.1
2.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
37
2.47
1.49
3.3
2.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
117
1.75
1.48
2.3
1.7
—
—
—
0
0
(4146454)
7
28
2.53
1.46
1.9
2.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
16
3.15
1.44
1.8
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
22
2.75
1.44
1.2
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
36
248
1.50
1.41
4.6
3.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
40
2.28
1.41
1.3
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
47
342
1.43
1.41
2.4
2.2
ug/g
136.7
152.6
0.19
37
264
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
41
2.22
1.38
1.2
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
120
1011
1.27
1.36
4.7
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
256
2354
1.26
1.35
4.6
3.8
pmol/l
15.1
14.7
1.70
241
2132
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
45
329
1.42
1.32
2.0
4.1
ug/l
3.0
36.8
0.93
36
278
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
24
2.52
1.31
1.2
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
81
652
1.31
1.30
1.2
1.3
u/ml
0.5
2.2
1.37
25
170
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
63
1.93
1.24
1.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
256
1.45
1.23
1.3
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
226
2062
1.23
1.22
3.7
2.9
u/l
48.3
50.2
0.15
216
1928
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
19
2.65
1.22
4.2
3.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
19
2.65
1.22
1.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
38
2.13
1.19
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
276
1.42
1.17
2.3
2.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
65
1.87
1.14
2.2
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
326
3113
1.31
1.12
4.4
4.2
mmol/l
4.7
4.7
0.63
311
2884
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
64
510
1.31
1.11
2.8
3.0
mmol/l
2.5
2.5
0.10
58
450
(21494755) Public health laboratory ask at order entry panel
21
312
0.65
1.09
1.2
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
105
894
1.24
1.07
3.8
3.9
mg/mmol
20.4
9.6
0.43
72
568
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
138
1.55
1.05
2.3
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
68
1.79
1.01
3.6
4.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
49
1.86
0.99
1.2
1.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
5
23
2.19
0.98
1.6
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
77
1.71
0.96
1.6
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
98
839
1.23
0.95
3.2
3.1
mg/l
89.5
467.8
1.35
68
528
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
37
1.91
0.94
1.7
2.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
37
1.91
0.94
1.4
1.9
ug/l
72.3
16.9
—
7
37
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
27
2.24
0.94
1.5
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
70
1.74
0.93
1.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
7
129
0.53
0.89
3.9
6.0
%
0.7
0.9
—
7
124
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
129
0.53
0.89
4.4
6.1
%
1.1
1.5
—
7
123
(3018418) pH of Serum or Plasma
97
835
1.22
0.89
4.1
4.0
ph
7.4
7.4
0.27
31
165
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
313
2996
1.24
0.89
4.2
3.8
mmol/l
1.3
1.3
0.27
296
2746
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
320
0.70
0.88
1.2
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
30
2.02
0.87
1.8
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
30
222
1.38
0.87
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
45
1.79
0.84
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
45
1.79
0.84
1.5
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
330
3182
1.26
0.84
4.6
4.7
mmol/l
2.8
2.8
0.78
316
2927
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
206
1.39
0.84
1.6
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
319
3066
1.24
0.83
4.5
4.2
mmol/l
5.8
5.9
0.83
301
2802
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
46
1.75
0.83
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
46
1.75
0.83
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
46
1.75
0.83
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
46
1.75
0.83
1.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
58
1.74
0.80
1.1
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
33
1.83
0.79
3.7
4.1
u/ml
19.0
98.3
—
6
33
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
33
1.83
0.79
5.8
2.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.4
—
1.1
—
0
26
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
12
75
1.62
0.75
1.5
1.5
g/l
0.0
0.0
0.00
12
67
(3009508) Creatinine [Moles/volume] in Urine
102
897
1.19
0.75
3.2
3.0
mmol/l
6.9
7.4
0.70
94
755
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
321
3096
1.22
0.75
4.4
4.2
mmol/l
1.5
1.5
0.02
306
2846
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
38
1.86
0.74
2.1
2.5
pg
31.6
32.3
—
7
38
(40768795) Lymph node Pathology biopsy report
7
38
1.86
0.74
1.4
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
38
1.86
0.74
1.1
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
12
76
1.60
0.72
1.5
1.4
g/l
36.3
38.2
0.69
12
65
(3007566) Smooth muscle Ab [Titer] in Serum
12
76
1.60
0.72
1.4
1.2
—
75.7
—
0
7
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
11
68
1.64
0.72
1.5
1.5
g/l
0.0
0.0
0.00
11
61
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
1.7
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
74
635
1.20
0.71
5.7
3.4
kg/l
1.0
1.0
0.02
21
80
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
26
1.93
0.71
1.2
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
11
69
1.61
0.69
1.5
1.5
g/l
0.0
0.0
0.00
11
61
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.2
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
27
1.86
0.68
1.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
28
1.80
0.66
2.2
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
8
130
0.61
0.65
3.4
3.7
mmol/l
26.1
24.0
—
8
120
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
15
105
1.45
0.61
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
151
0.65
0.61
24.2
10.7
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
12.7
—
885.3
—
0
20
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
18.2
—
1651.9
—
0
20
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
24
309
0.76
0.60
2.1
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
52
1.55
0.60
5.1
3.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
84
743
1.17
0.58
3.5
2.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
13
183
0.70
0.57
4.4
7.3
mmol/l
24.7
24.6
0.06
13
173
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
53
452
1.20
0.56
2.9
2.5
e6/l
0.8
1.2
0.43
34
241
(3002173) Hemoglobin [Mass/volume] in Arterial blood
21
271
0.76
0.54
13.0
8.6
g/l
124.3
122.4
0.14
21
264
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
106
961
1.14
0.53
2.9
3.3
u/l
31.8
31.8
0.00
100
920
(4035726)
34
280
1.24
0.51
1.6
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.6
2.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
12
86
1.41
0.45
1.5
1.6
g/l
0.1
1.2
2.13
12
77
(3025941) Bacteria identified in Stool by Culture
20
157
1.29
0.44
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
258
1.22
0.43
1.1
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
93
848
1.13
0.43
4.6
4.5
ug/l
2.4
3.1
0.55
84
766
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
34
1.48
0.40
1.0
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
71
1.42
0.39
1.4
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
805
0.88
0.39
1.6
1.7
mmol/l
1.5
1.3
0.58
66
664
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
2.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
17
214
0.78
0.39
3.9
2.6
kpa
4.3
4.5
0.21
17
203
(3026389) Candida sp identified in Specimen by Organism specific culture
5
36
1.39
0.38
1.6
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
36
1.39
0.38
3.4
3.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
42
1.44
0.35
2.7
2.4
mmol/l
3.8
4.0
—
6
42
(3035285) Chloride [Moles/volume] in Venous blood
6
42
1.44
0.35
2.7
2.4
mmol/l
105.0
104.3
—
6
42
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
42
1.44
0.35
2.7
2.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
43
1.40
0.35
1.3
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
43
1.40
0.35
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
80
870
0.90
0.34
4.2
2.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
2.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
45
1.34
0.34
2.8
1.9
pmol/l
161.7
210.4
—
6
40
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
229
0.82
0.31
1.3
1.2
iu/ml
86.3
143.6
—
8
91
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
96
0.72
0.31
2.4
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
53
1.33
0.31
3.9
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
141
0.77
0.30
1.8
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.6
2.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
63
1.28
0.28
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
9
119
0.75
0.27
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
32
281
1.15
0.27
1.5
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
310
0.86
0.27
1.8
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
159
1.21
0.27
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
58
534
1.10
0.24
3.1
3.6
ng/l
115.3
500.6
1.47
33
408
(3019060) Gas panel - Arterial blood
16
190
0.84
0.24
4.2
5.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
106
1.23
0.23
1.5
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
7
95
0.73
0.22
4.9
4.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
154
1.18
0.21
4.2
3.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
4.2
—
0
10
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
23.2
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.9
—
0.7
—
0
12
(3042733) HLA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
4.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
43
1.16
0.21
1.4
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.3
—
15.7
—
0
9
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
50
1.20
0.20
1.2
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
186
0.85
0.19
1.6
1.7
—
—
—
0
0
(4010399)
26
232
1.13
0.19
1.6
1.4
—
—
—
0
0
(3012544) pH of Venous blood
30
271
1.12
0.18
3.6
3.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
69
1.16
0.16
1.5
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
72
1.11
0.16
1.6
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
83
1.21
0.15
2.2
2.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
79
1.14
0.15
1.1
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
102
1.18
0.15
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
89
0.78
0.14
3.3
4.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
41
439
0.93
0.14
3.0
2.6
e6/l
2.7
2.8
0.01
21
229
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
25
227
1.11
0.14
2.0
2.7
ng/l
136.7
179.5
0.29
20
212
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
98
0.81
0.14
1.4
1.5
—
—
—
0
0
(4034850)
9
107
0.84
0.13
8.6
9.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
73
699
1.05
0.13
4.0
4.0
%
21.2
21.6
0.08
38
332
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
354
0.93
0.12
7.2
6.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
48
507
0.94
0.12
3.7
2.8
ug/l
0.8
0.9
0.16
39
326
(3026782) Osmolality of Urine
60
574
1.05
0.11
3.1
2.6
mosm/kgh2o
541.5
550.9
0.15
53
490
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
208
0.91
0.10
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
44
1.14
0.10
1.4
1.4
mmol/l
7.5
7.0
—
5
29
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
114
0.87
0.09
1.3
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
48
1.04
0.09
1.2
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
50
522
0.95
0.09
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
325
3227
1.05
0.09
19.0
12.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
175
1.09
0.08
2.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
107
1.13
0.08
1.8
2.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
146
1.10
0.08
1.5
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
61
0.82
0.08
1.2
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
63
0.79
0.08
1.2
8.0
—
235.7
—
0
12
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
83
0.84
0.07
1.7
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
132
0.91
0.06
1.2
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
103
0.87
0.06
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
82
839
0.97
0.06
1.5
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
19
188
1.01
0.00
2.0
3.1
u/ml
34.4
69.6
0.74
19
181
(3021447) Carbon dioxide [Partial pressure] in Venous blood
26
261
1.00
0.00
4.0
3.5
kpa
6.0
5.8
0.59
26
250
(3002032) Base excess in Venous blood by calculation
26
259
1.00
0.00
4.1
3.6
mmol/l
2.3
1.9
0.34
20
196
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
133
0.98
0.00
3.7
2.4
%
1.0
1.2
1.00
13
133
(3047181) Lactate [Moles/volume] in Blood
10
95
1.05
0.00
3.3
8.2
mmol/l
1.2
1.2
—
10
84
(3000991) Gas panel - Venous blood
22
224
0.98
0.00
12.7
8.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.9
—
12.0
—
0
9
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
55
0.91
0.00
1.2
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
24.2
—
0
8
(3006576) Bicarbonate [Moles/volume] in Blood
0
9
0.00
0.00
0.0
6.7
—
26.8
—
0
9
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
2.2
—
117.0
—
0
9
(44806420)
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
50
1.00
0.00
1.2
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
7.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
52.8
—
0
5
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
84
0.95
0.00
1.6
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
92
0.98
0.00
1.6
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
30.1
—
0
7
(4094501)
8
87
0.92
0.00
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
84
0.95
0.00
1.6
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
116.4
—
0
5
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
74.2
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint M13_PALINDROMIC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PALINDROMIC | 1.065 [0.85, 1.33] | 0.575 |
| Birth year | 0.998 [0.99, 1.01] | 0.617 |
During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 915 females with M13_PALINDROMIC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PALINDROMIC | 1.457 [1.19, 1.78] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 583 males with M13_PALINDROMIC died.
Mortality risk
Mortality risk for people of age
years, who have M13_PALINDROMIC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.084% | 0.246% |
| 5 | 0.568% | 1.694% |
| 10 | 1.612% | 4.199% |
| 15 | 3.344% | 7.854% |
| 20 | 5.978% | 13.26% |
Relationships between endpoints
↥Index endpoint: M13_PALINDROMIC – Palindromic rheumatism
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data